摘要
目的评估氩离子凝固术(APC)联合质子泵抑制剂(PPI)逆转Barrett食管(BE)的长期疗效。方法对2004年至2007年经胃镜检查并经病理证实的36例BE患者采用APC联合PPI(每天20mg)治疗,分别于治疗后第1、6、12个月复查,以后每年1次内镜随访。结果36例患者共行48次APC治疗,平均1.33次/例,经治疗后均获得BE完全逆转。随访14~51个月,中位时间36个月,BE总复发率为16.7%(6/36),1年复发率为2.8%(1/36),2年复发率为11.1%(4/36)。Logistic回归分析显示,2年复发率和总复发率与APC治疗次数呈明显正相关(P值分别为0.004和0.007)。结论APC联合PPI治疗BE是一种安全、有效的方法,且长期疗效较好。
Objective To study the long-term effect of argon plasma coagulation (APC) combined with proton pump inhibitor (PPI) on Barrett esophagus (BE). Methods A total of 36 patients, histologically proven as having BE from 2004 to 2007, were enrolled to underwent a therapy of APC plus PPI. The patients were re-examined on endoscopy at l, 6 and 12 months after first APC and once a year thereafter. Results A total of 48 APC sessions were given to 36 patients with a mean number at 1.33 per patient. The effective rate of reversal of BE was 100%. The follow-up was accomplished for all patients in 14-51 months with a median of 36months. The total recurrence rate (RR) of BE reached 16.7% (6/36). The 1-year and 2-year RRs were 2. 8% (1/36) and 11. 1% (4/36) , respectively. The logistic regression analysis sugges- ted that 2-year and total RRs were related to APC sessions ( P 〈 0. 01 ). Conclusion The therapy of APC combined with PPI for BE is safe and of long-term effects.
出处
《中华消化内镜杂志》
北大核心
2011年第2期76-79,共4页
Chinese Journal of Digestive Endoscopy
基金
浦东新区科技发展基金创新资金(PKJ2007-15)